ZLQ-54693-91485
2 vaccinations
2 coded responses
5 check-ins
2 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 494 / MI
- Registered
- 2022-09-10
- Relationship
- Child or adolescent in my care
- Guardian
- 287-47840-77461
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-09-06
Dose 1 — Pfizer-BioNTechCo-administered: Do not remember
-
2022-09-10
Registered in v-safe
-
2022-09-10
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain, Redness · Loss of appetiteUnder 3 check-in
-
2022-09-20
Survey response — day 14, dose 1, under 3MedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fever, runny nose, barking coughMedDRA releases: 2024-11 · check-in free text available
-
2022-09-20
Report sent to call center — day 14, dose 1, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-09-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-09-27
-
2022-09-30
Dose 2 — Pfizer-BioNTech
- 2022-10-11
-
2022-10-23
Survey response — day 21, dose 2, under 3MedDRA: Cough, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Hacking cough · Healthcare visit (other): In person dr. ApptMedDRA releases: 2024-11 · check-in free text available
-
2022-10-23
Report sent to call center — day 21, dose 2, under 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-10-25
- 2022-10-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-09-06 | Pfizer-BioNTech | Do not remember |
| 2 | 2022-09-30 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-09-20 | Successful 2022-09-21 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-10-23 | Unsuccessful |
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: Fever, runny nose, barking cough
Release 12 (Under 3) — day 21, dose 2, under 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release